|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 524.24 USD | +0.38% |
|
+5.14% | +15.20% |
| 03:15pm | Jefferies Adjusts Vertex Pharmaceuticals Price Target to $610 From $580 | MT |
| 07-07 | IBT company Crinetics to be acquired by Vertex for USD10 billion | AN |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 552.68 | +5.83% | 25 | ||||||
| 1,228.25 | -0.59% | 28 | ||||||
| 257.95 | -3.47% | 22 | ||||||
| 258.32 | +1.44% | 28 | ||||||
| 359.22 | +5.81% | 18 | ||||||
| 153.92 | -2.1% | 21 | ||||||
| 316.91 | -3.22% | 24 | ||||||
| 354.97 | -3.57% | 29 | ||||||
| 158.37 | +16.14% | 27 | ||||||
| 29 | +20.49% | 27 | ||||||
| 63 | +8.68% | 24 | ||||||
| 21.14 | +5.55% | 19 | ||||||
| 96.49 | +27.33% | 23 | ||||||
| 10,006.67 | +31.32% | 15 | ||||||
| 53.69 | +5.66% | 18 | ||||||
| 81.21 | +46.7% | 15 | ||||||
| 6,106.87 | +12.09% | 15 | ||||||
| 4.142 | +13.36% | 17 | ||||||
| 437.5 | +36.04% | 24 | ||||||
| Average | 1,081.07 | +11.76% | 22 | ||||||
| Weighted average by Cap. | 736.23 | +3.80% | 24 |
- Stock Market
- Stocks
- VRTX Stock
- Sector Vertex Pharmaceuticals Incorporated
- Sector consensus
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
